# Parcel-guided rTMS for Major Depressive Disorder

> **NCT07287839** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Soterix Medical** · enrollment: 60 (estimated)

## Conditions studied

- Treatment Resistant Depression (TRD)

## Interventions

- **DEVICE:** Accelerated rTMS
- **DEVICE:** Parcel-guided Accelerated rTMS

## Key facts

- **NCT ID:** NCT07287839
- **Lead sponsor:** Soterix Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07287839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07287839, "Parcel-guided rTMS for Major Depressive Disorder". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT07287839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*